152 filings
8-K
RVNC
Revance Therapeutics Inc
9 May 24
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
4:08pm
8-K
RVNC
Revance Therapeutics Inc
3 May 24
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
RVNC
Revance Therapeutics Inc
5 Mar 24
Other Events
5:08pm
8-K
RVNC
Revance Therapeutics Inc
28 Feb 24
Provides Corporate Update
4:07pm
8-K
RVNC
Revance Therapeutics Inc
13 Feb 24
Departure of Directors or Certain Officers
4:28pm
8-K
m9rx5a
6 Feb 24
Departure of Directors or Certain Officers
4:04pm
8-K
b39bzm3r3k
8 Jan 24
Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook
8:01am
8-K
pi5gzqqid31swz
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
uek3ka3w
8 Nov 23
Provides Corporate Update
4:09pm
8-K
x75f fnva
19 Sep 23
Revance Provides Corporate Update at Investor Day
9:01am
8-K
rwqzsg36c amxteu7vu
30 Aug 23
Other Events
7:20pm
8-K
0ybolybo33c
14 Aug 23
Other Events
8:02am
8-K
nylu382qem
8 Aug 23
Provides Corporate Update
4:08pm
8-K
zn1kvep01 fnrn
9 May 23
Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update
4:07pm
8-K
8rojvzlvt
8 May 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
85v qvh0a
19 Apr 23
Regulation FD Disclosure
4:06pm
8-K
e4w 97mdo
28 Feb 23
Provides Corporate Update
4:10pm
8-K
i3ksqup1itjhd
3 Feb 23
Departure of Directors or Certain Officers
4:05pm
8-K
8c603ssokzv1xivtxh3d
18 Jan 23
Entry into a Material Definitive Agreement
4:48pm
8-K
0wofqdyucb2k0s
9 Jan 23
Revance Provides an Update on DAXXIFY® Commercial Launch and Preliminary Fourth Quarter and Full Year 2022 Financial Results
8:02am